The retrospective study as the 1st-line chemotherapy of fluorouracil and bevacizumab for the frail-patients with unresectable or metastatic colorectal cancer

ABSTRACT: Primary outcome(s): PFS, OS, RR, DCR, Adverse event

DISEASE(S): Colorectal Cancer

PROVIDER: 2624900 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR